Splenomegaly with platelet sequestration
Increased platelet destruction by an immune mechanism; can occur as a result of:
Heparin-induced thrombocytopenia (HIT)
Idiopathic or immune thrombocytopenic purpura (ITP)
Drug (other than heparin)-induced thrombocytopenia
Post-transfusion purpura (PTP)
Increased platelet destruction by non-immune mechanisms, as caused by:
Hemolytic uremic syndrome (HUS)
Thrombotic thrombocytopenic purpura (TTP)
Decreased platelet production most often occurs after exposure to drugs (e.g., chemotherapeutic agents) that suppress synthesis of new platelets or by infiltration of the marrow by tumor or other structures.
Suggested Additional Lab Testing
Platelet count establishes presence or absence of thrombocytopenia; 100,000 functional platelets/µL is usually considered adequate for any challenge to hemostasis.
Workup for DIC:
D-dimer or FDP
Peripheral blood smear to check for schistocytes
Test for HIT:
Most often available is ELISA for antibody to platelet factor 4/heparin complex
ITP is a diagnosis of exclusion.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Clinical Pain Advisor Articles
- Cannabis Use High in Migraine
- Sustained-Release Sodium Nitrite for Diabetic Neuropathic Pain Not Associated With Headaches
- Treatment for Opioid Use Disorder Associated With Reduced Risk for Opioid-Related Deaths
- Percutaneous Electrolysis May Be Useful Adjunct for Subacromial Pain Syndrome
- Clonidine May Not Improve Post-Cesarean Delivery Analgesia
- Recommendations for Perioperative Pain Management in Patients With Opioid Tolerance
- Vertebroplasty Comparable With Placebo for Acute Vertebral Compression Fractures
- Capsaicin 8% Patch May Be Effective in Neuropathic Pain
- Detox vs Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Expert Roundtable
- Prior Authorization Policy May Help Reduce Long-Acting Opioid Use